Business description: TearLab Corporation

Sales by Activity: TearLab Corporation
| Fiscal Period: December | 2019 (USD) |
|---|---|
Diagnostic Kits / Equipment | 22.66M |
Geographical breakdown of sales: TearLab Corporation
| Fiscal Period: December | 2019 (USD) |
|---|---|
United States | 21.29M |
Rest of the World | 1.37M |
Executive Committee: TearLab Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Adam Szaronos
CEO | Chief Executive Officer | - | 2026-03-31 |
| Chief Tech/Sci/R&D Officer | - | 2009-07-16 | |
John Lund
DFI | Director of Finance/CFO | 60 | 2022-06-30 |
Steve Zmina
CTO | Chief Tech/Sci/R&D Officer | - | 2006-09-30 |
Michael Berg
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Composition of the Board of Directors: TearLab Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Uri Geiger
BRD | Director/Board Member | 58 | 2020-07-08 |
James V. Mazzo
CHM | Chairman | 68 | 2021-12-08 |
| Director/Board Member | 78 | 2004-08-31 | |
Dolev Rafaeli
BRD | Director/Board Member | 62 | - |
Barak Azmon
BRD | Director/Board Member | - | - |
David Carter
BRD | Director/Board Member | - | - |
Douglas Strang
BRD | Director/Board Member | - | - |
Company details: TearLab Corporation

Glasses, Spectacles & Contact Lenses
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.24% | -0.34% | -40.76% | -5.94% | 86.53B | ||
| -0.81% | -3.10% | -7.95% | -19.76% | 35.87B | ||
| +0.05% | -0.07% | +4.21% | -18.17% | 14.85B | ||
| +1.01% | +10.81% | - | - | 11.9B | ||
| +1.22% | +4.61% | -10.88% | +683.53% | 2.44B | ||
| -3.25% | -6.38% | -43.01% | -59.26% | 1.51B | ||
| -1.08% | -2.74% | +58.29% | -6.52% | 908M | ||
| -0.53% | +0.54% | +19.81% | +9.41% | 899M | ||
| -0.64% | -0.07% | -40.01% | -20.90% | 885M | ||
| Average | -0.28% | +0.75% | -7.54% | +70.30% | 17.31B | |
| Weighted average by Cap. | +0.61% | -0.24% | -26.45% | +0.47% |

















